Canada Markets open in 7 hrs 30 mins

BELLUS Health Inc. (BLU)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
12.00+0.37 (+3.18%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close11.63
Open11.72
Bid0.00 x 1100
Ask0.00 x 800
Day's Range11.56 - 12.65
52 Week Range2.94 - 12.65
Volume1,843,700
Avg. Volume1,089,527
Market Cap1.242B
Beta (5Y Monthly)-0.55
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    BELLUS Health Closes US$153 Million Public Offering of Common Shares in Canada and the United States

    LAVAL, Quebec, July 18, 2022--BELLUS Health Inc. (NASDAQ: BLU)(TSX: BLU) (the "Company" or "BELLUS Health") announced today that it has completed its previously-announced underwritten public offering in Canada and the United States (the "Offering") of 16,540,541 common shares at a price to the public of US$9.25 per common share. The total gross proceeds to the Company were US$153 million, before deducting the underwriting commissions and any expenses related to the Offering. Bellus has also gran

  • Business Wire

    BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States

    LAVAL, Quebec, July 14, 2022--In connection with its previously announced public offering of common shares in Canada and the United States (the "Offering"), BELLUS Health Inc. ("BELLUS Health" or the "Company") (TSX and Nasdaq: BLU) today announced that it has entered into an underwriting agreement with Jefferies, Evercore ISI and RBC Capital Markets as joint book-running managers and LifeSci Capital as lead manager (collectively, the "Underwriters"), relating to the public offering of 16,540,54

  • Business Wire

    BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States

    LAVAL, Quebec, July 13, 2022--BELLUS Health Inc. ("BELLUS Health" or the "Company") (TSX and Nasdaq: BLU), announced today the filing of a preliminary prospectus supplement (the "Supplement") to its amended and restated short form base shelf prospectus dated December 14, 2021, amending and restating the short form base shelf prospectus dated December 23, 2020 (the "A&R Base Prospectus") in connection with a proposed public offering of its common shares (the "Offering"). The Supplement was filed